|
Institut Carnot CALYM (French: Consortium pour l’Accélération de l’innovation et de son transfert dans le domaine du LYMphome, or Consortium to Accelerate Innovation and the Transfer in the Domain of Lymphoma) is a research consortium that brings together 13 French research entities with preclinical and clinical research expertise in the field of lymphoma: 11 high-profile research teams specialized in the lymphoma field, and hospitals for clinical and translational research federated around a world-renowned cooperative group, the LYSA and an operational structure to carry studies, the LYSARC. The consortium aims to accelerate innovation and transfer in the field of lymphoma in the areas of therapeutic, diagnostic and imaging. The steering committee of CALYM consortium is led by Prof. Gilles Salles, and the Executive Director is Pascal Deschaseaux. Carnot Institute is a label of excellence awarded by the French Ministry of Research to public-parapublic research institutes with a strong track record of partnering research. == Major medical and industrial challenges == * About 2 million people worldwide living with lymphoma * The incidence has doubled since the 1970s, with 12,000 new cases reported in France and more than 70,000 in Europe * A strong emergence of biotechnologies and technologies for diagnosis and imaging 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「CALYM」の詳細全文を読む スポンサード リンク
|